Telomerase maintains telomere structure in normal human cells

Cell

Volumn 114, Issue 2, 2003, Pages 241-253

  Masutomi, Kenkichi ^a   Yu, Evan Y ^a   Khurts, Shilagardy ^b   Ben Porath, Ittai ^c   Currier, Jennifer L ^a   Metz, Geoffrey B ^a   Brooks, Mary W ^c   Kaneko, Shuichi ^d   Murakami, Seishi ^b   DeCaprio, James A ^a   Weinberg, Robert A ^c   Stewart, Sheila A ^c   Hahn, William C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KANAZAWA UNIVERSITY   (Japan)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CATALYSIS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TELOMERE;

EID: 0043199578     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00550-6     Document Type: Article

References (60)

1. Allsopp R.C., Cheshier S., Weissman I.L. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J. Exp. Med. 193:2001;917-924.
2. Artandi S.E., Alson S., Tietze M.K., Sharpless N.E., Ye S., Greenberg R.A., Castrillon D.H., Horner J.W., Weiler S.R., Carrasco R.D.et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA. 99:2002;8191-8196.
3. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
4. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
5. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
6. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA. 92:1995;9082-9086.
7. Cimino-Reale G., Pascale E., Battiloro E., Starace G., Verna R., D'Ambrosio E. The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res. 29:2001;E35.
8. Counter C.M., Avilion A.A., Le Feuvre C.E., Stewart N.G., Greider C.W., Harley C.B., Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11:1992;1921-1929.
9. Counter C.M., Hahn W.C., Wei W., Caddle S.D., Beijersbergen R.L., Lansdorp P.M., Sedivy J.M., Weinberg R.A. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl. Acad. Sci. USA. 95:1998;14723-14728. a.
10. Counter C.M., Meyerson M., Eaton E.N., Ellisen L.W., Caddle S.D., Haber D.A., Weinberg R.A. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene. 16:1998;1217-1222. b.
11. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O.M.et al. A biomarker that identifies senescent human cells in culture and in aging in skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
12. Dionne I., Wellinger R.J. Cell cycle-regulated generation of single-stranded G-rich DNA in the absence of telomerase. Proc. Natl. Acad. Sci. USA. 93:1996;13902-13907.
13. Enomoto S., Glowczewski L., Berman J. MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae. Mol. Biol. Cell. 13:2002;2626-2638.
14. Etheridge K.T., Banik S.S., Armbruster B.N., Zhu Y., Terns R.M., Terns M.P., Counter C.M. The nucleolar localization domain of the catalytic subunit of human telomerase. J. Biol. Chem. 277:2002;24764-24770.
15. Feng J., Funk W.D., Wang S.S., Weinrich S.L., Avilion A.A., Chiu C.P., Adams R.R., Chang E., Allsopp R.C., Yu J.et al. The RNA component of human telomerase. Science. 269:1995;1236-1241.
16. Gonzalez-Suarez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26:2000;114-117.
17. Goytisolo F.A., Samper E., Edmonson S., Taccioli G.E., Blasco M.A. The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21:2001;3642-3651.
18. Greider C.W., Blackburn E.H. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature. 337:1989;331-337.
19. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., de Lange T. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
20. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumor cells with defined genetic elements. Nature. 400:1999;464-468. a.
21. Hahn W.C., Stewart S.A., Brooks M.W., York S.G., Eaton E., Kurachi A., Beijersbergen R.L., Knoll J.H., Meyerson M., Weinberg R.A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5:1999;1164-1170. b.
22. Hahn W.C., Dessain S.K., Brooks M.W., King J.E., Elenbaas B., Sabatini D.M., DeCaprio J.A., Weinberg R.A. Enumeration of SV40 elements necessary for human cell transformation. Mol. Biol. Cell. 22:2002;2111-2123.
23. Hara E., Tsurui H., Shinozaki A., Nakada S., Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179:1991;528-534.
24. Harle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA. 93:1996;6476-6481.
25. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
26. Harley C.B., Kim N.W., Prowse K.R., Weinrich S.L., Hirsch K.S., West M.D., Bacchetti S., Hirte H.W., Counter C.M., Greider C.W.et al. Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59:1994;307-315.
27. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:1995;3711-3715.
28. Hiyama E., Hiyama K., Tatsumoto N., Kodama T., Shay J.W., Yokoyama T. Telomerase activity in human intestine. Int. J. Oncol. 9:1996;453-458.
29. IJpma A.S., Greider C.W. Short telomeres induce a DNA damage response in Saccharomyces cerevisiae. Mol. Biol. Cell. 14:2003;987-1001.
30. Jacob N.K., Kirk K.E., Price C.M. Generation of telomeric G strand overhangs involves both G and C strand cleavage. Mol. Cell. 11:2003;1021-1032.
31. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2449.
32. Kilian A., Bowtell D.D.L., Abud H.E., Hime G.R., Venter D.J., Keese P.K., Duncan E.L., Reddel R.R., Jefferson R.A. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:1997;2011-2019.
33. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
34. Kipling D., Cooke H.J. Hypervariable ultra-long telomeres in mice. Nature. 347:1990;400-402.
35. Kirk K.E., Harmon B.P., Reichardt I.K., Sedat J.W., Blackburn E.H. Block in anaphase chromosome separation caused by a telomerase template mutation. Science. 275:1997;1478-1481.
36. Kolquist K.A., Ellisen L.W., Counter C.M., Meyerson M., Tan L.K., Weinberg R.A., Haber D.A., Gerald W.L. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues. Nat. Genet. 19:1998;182-186.
37. Li G.Z., Eller M.S., Firoozabadi R., Gilchrest B.A. Evidence that exposure of the telomere 3′ overhang sequence induces senescence. Proc. Natl. Acad. Sci. USA. 100:2003;527-531.
38. Liu K., Schoonmaker M.M., Levine B.L., June C.H., Hodes R.J., Weng N.P. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc. Natl. Acad. Sci. USA. 96:1999;5147-5152.
39. Martin-Rivera L., Herrera E., Albar J.P., Blasco M.A. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA. 95:1998;10471-10476.
40. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science. 297:2002;565-569.
41. Masutomi K., Kaneko S., Hayashi N., Yamashita T., Shirota Y., Kobayashi K., Murakami S. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J. Biol. Chem. 275:2000;22568-22573.
42. Matthews P., Jones C.J., Skinner J., Haughton M., de Micco C., Wynford-Thomas D. Telomerase activity and telomere length in thyroid neoplasia. biological and clinical implications J. Pathol. 194:2001;183-193.
43. Nakamura T.M., Cech T.R. Reversing time. origin of telomerase Cell. 92:1998;587-590.
44. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science. 277:1997;955-959.
45. Nikaido R., Haruyama T., Watanabe Y., Iwata H., Iida M., Sugimura H., Yamada N., Ishikawa F. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells. 4:1999;563-572.
46. Shay J.W., Wright W.E. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184:1989;109-118.
47. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348.
48. Son N.H., Murray S., Yanovski J., Hodes R.J., Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J. Immunol. 165:2000;1191-1196.
49. Steinert S., Shay J.W., Wright W.E. Transient expression of human telomerase extends the life span of normal human fibroblasts. Biochem. Biophys. Res. Commun. 273:2000;1095-1098.
50. Stewart S.A., Ben-Porath I., Carey V.C., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33:2003;492-496. a.
51. Stewart S.A., Dykxhoorn D.M., Palliser D., Mizuno H., Yu E.Y., Eisen H.N., Sabatini D.M., Hahn W.C., Sharp P.A., Weinberg R.A.et al. Stable silencing of gene expression in primary cells by retroviral delivery of RNAi. RNA. 9:2003;493-501. b.
52. Taggart A.K., Teng S.C., Zakian V.A. Est1p as a cell cycle-regulated activator of telomere-bound telomerase. Science. 297:2002;1023-1026.
53. Tahara H., Yasui W., Tahara E., Fujimoto J., Ito K., Tamai K., Nakayama J., Ishikawa F., Ide T. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene. 18:1999;1561-1567.
54. Ulaner G.A., Hu J.F., Vu T.H., Giudice L.C., Hoffman A.R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res. 58:1998;4168-4172.
55. Vaziri H., Squire J.A., Pandita T.K., Bradley G., Kuba R.M., Zhang H., Gulyas S., Hill R.P., Nolan G.P., Benchimol S. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol. Cell. Biol. 19:1999;2373-2379.
56. Wei W., Sedivy J.M. Differentiation between senescence (M1) and crisis (M2) in human fibroblast cultures. Exp. Cell Res. 253:1999;519-522.
57. Wong J.M., Kusdra L., Collins K. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 4:2002;731-736.
58. Wright W.E., Shay J.W. Historical claims and current interpretations of replicative aging. Nat. Biotechnol. 20:2002;682-688.
59. Yasumoto S., Kunimura C., Kikuchi K., Tahara H., Ohji H., Yamamoto H., Ide T., Utakoji T. Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
60. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H.W., Dhingra U., Sokoloski J.A., Hsiao R., Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA. 93:1996;6091-6095.